SCHEMBL3346872

SCHEMBL3346872

Nc1cc(-n2ncccc2=O)ccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
F10 P00742 1/20 0.39
HRH3 Q9Y5N1 4/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.36
P2RX7 Q99572 1/20 0.35
BRD4 O60885 1/20 0.34
PARP1 P09874 1/20 0.34
KAT2B Q92831 1/20 0.33
POLB P06746 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ESR1 P03372 1/20 0.32
HPGD P15428 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3834632 0.88 CA1 (0.51) CA1CA2CA12CA9F10
SCHEMBL10584952 0.81 CA12 (0.51) CA1CA2CA12CA9F10
SCHEMBL3343676 0.81 CA12 (0.51) CA1CA2CA12CA9HRH3
SCHEMBL6525689 0.81 CA12 (0.44) CA1CA2CA12CA9F10
SCHEMBL3346868 0.80 CA12 (0.47) CA1CA2CA12CA9F10
SCHEMBL14955412 0.77 CA12 (0.49) CA1CA2CA12CA9F10
SCHEMBL5111285 0.77 CA12 (0.47) CA1CA2CA12CA9F10
SCHEMBL4670546 0.76 CA12 (0.65) CA1CA2CA12CA9HRH3
SCHEMBL29151055 0.76 CA1 (0.60) CA1CA2CA12CA9HRH3
SCHEMBL29488639 0.76 CA12 (0.47) CA1CA2CA12CA9HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 CA1 3996/4885CA2 2648/4885CA12 4790/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 CA1 3391/4885CA2 2046/4885CA12 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.